Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04348136

An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II

Status
Active Not Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
27 (actual)
Sponsor
JCR Pharmaceuticals Co., Ltd. · Industry
Sex
Male
Age
—
Healthy volunteers
Not accepted

Summary

Multicenter, open-label, single-group, designed to evaluate the long term efficacy and safety of study drug for the treatment of the MPS II.

Conditions

Interventions

TypeNameDescription
DRUGJR-141IV infusion, 2.0 mg/kg/week

Timeline

Start date
2019-09-01
Primary completion
2030-03-31
Completion
2030-03-31
First posted
2020-04-16
Last updated
2025-07-24

Locations

20 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT04348136. Inclusion in this directory is not an endorsement.

An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II (NCT04348136) · Clinical Trials Directory